Health Canada Approves Ocrevus for Pediatric Relapsing-Remitting MS
Health Canada approved Roche Canada's Ocrevus (ocrelizumab) for treating pediatric relapsing-remitting multiple sclerosis.
Related stories
Spain’s CNMC Opens Disciplinary Proceedings Against Apple and Amazon
Spain’s competition regulator CNMC has launched disciplinary proceedings against Apple and Amazon.
M impact | REGULATION | Nov 03, 2026, 03:05 PM UTC
CFTC Clears Perpetual Futures on Stocks
The Commodity Futures Trading Commission cleared perpetual futures on stocks, bringing a crypto-style trading model to Wall Street.
M impact | REGULATION | Nov 03, 2026, 03:04 PM UTC
Trump Says US Will End $4 Billion in Funding to Israel in 2026
Trump said the United States will stop funding Israel at the end of 2026.
M impact | REGULATION | Nov 03, 2026, 02:55 PM UTC
Italy to Buy Back Five Bonds for Up to €5 Billion
Italy's Treasury said it would repurchase four BTP bonds and one floating-rate CCTeu certificate, maturing in 2027 and 2028, on Thursday using cash reserves held at the Bank of Ita
L impact | REGULATION | Nov 03, 2026, 02:53 PM UTC
Shanying International Says Chairman Under Investigation by China Regulator
The company says the securities regulator is investigating its chairman over suspected insider trading and short-swing trading violations.
M impact | REGULATION | Nov 03, 2026, 02:48 PM UTC
Istanbul Stock Exchange Chief Remanded in Fraudulent Funds Scandal
The head of the Istanbul Stock Exchange has been remanded in custody in connection with a fraudulent funds scandal.
M impact | REGULATION | Nov 03, 2026, 02:35 PM UTC